Du var ju nyss övertygad själv om att stopphormoner var rätt väg att gå? Min poäng är att människor som inte har varken egen erfarenhet eller expertis alltid verkar få uttrycka sig före transpersoner och oss som har olika expertis i ämnet i den här debatten. SBU har också problematiserats och kritiserats av många av oss, och definitivt i sättet som den används nu som bas för beslut som i min mening inte stöds av utredningen, som endast tagit hänsyn till vissa aspekter, och ignorerat många andra. Den går också emot slutsatser som drogs i en tidigare utredning 2017 (SOU 2017:92), vilket jag också tagit upp när vi fick utredningen på remiss. Jag var även en del av remissinstansen för utredningen 2017. Tyvärr kan jag inte säga mer än så kring det för att behålla min anonymitet på forumet.
Här har du en lista av källor kring pubertetsblockerare och behandling av unga transpersoner. Klippt från en sammanställning jag råkade ha på datorn just nu.
[1] Hembree, W. C., Cohen-Kettenis, P., Delemarre-van de Waal, H. A., Gooren, L. J., Meyer III, W. J., Spack, N. P., ... & Montori, V. M. (2009). Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology & Metabolism, 94(9), 3132-3154.
[2] Coleman, E., Bockting, W., Botzer, M., Cohen-Kettenis, P.,... & Zucker, K. (2012). Standards of care for the health of transsexual, transgender, and gender-nonconforming people, version 7.International Journal of Transgenderism, 13(4), 165-232. [3] Cohen‐Kettenis, P. T., Delemarre‐van de Waal, H. A., & Gooren, L. J. (2008). The treatment of adolescent transsexuals: Changing insights. The Journal of Sexual Medicine, 5(8), 1892-1897.
[4] Olson, J., Forbes, C., & Belzer, M. (2011). Management of the transgender adolescent. Archives of Pediatrics & Adolescent Medicine, 165(2), 171-176.
[5] Delemarre-van de Waal, H. A. (2014). Early medical intervention in adolescents with gender dysphoria. In Gender Dysphoria and Disorders of Sex Development (pp. 193-203). Springer US.
[6] Spack, N. P., Edwards-Leeper, L., Feldman, H. A., Leibowitz, S., Mandel, F., Diamond, D. A., & Vance, S. R. (2012). Children and adolescents with gender identity disorder referred to a pediatric medical center. Pediatrics, 129(3), 418-425.
[7] Mul, D., & Hughes, I. A. (2008). The use of GnRH agonists in precocious puberty. European Journal of
Endocrinology, 159(suppl 1), S3-S8.
[8] Heger, S., Partsch, C. J., & Sippell, W. G. (1999). Long-term outcome after depot gonadotropin-releasing hormone agonist treatment of central precocious puberty: Final height, body proportions, body composition, bone mineral density, and reproductive function. Journal of Clinical Endocrinology & Metabolism, 84(12), 4583-4590.
[9] van der Sluis, I. M., Boot, A. M., Krenning, E. P., Drop, S. L., & de Muinck Keizer-Schrama, S. M. (2002). Longitudinal follow-up of bone density and body composition in children with precocious or early puberty before, during and after cessation of GnRH agonist therapy. Journal of Clinical Endocrinology & Metabolism, 87(2), 506-512.
[10] Pasquino, A. M., Pucarelli, I., Accardo, F., Demiraj, V., Segni, M., & Di Nardo, R. (2008). Long-term observation of 87 girls with idiopathic central precocious puberty treated with gonadotropin-releasing hormone analogs: impact on adult height, body mass index, bone mineral content, and reproductive function. Journal of Clinical Endocrinology & Metabolism, 93(1), 190-195.
[11] Bertelloni, S., & Mul, D. (2008). Treatment of central precocious puberty by GnRH analogs: long‐term outcome in men. Asian Journal of Andrology, 10(4), 525-534.
[12] Tanaka, T., Niimi, H., Matsuo, N., Fujieda, K., Tachibana, K., Ohyama, K., ... & Kugu, K. (2005). Results of long-term follow-up after treatment of central precocious puberty with leuprorelin acetate: evaluation of effectiveness of treatment and recovery of gonadal function. The TAP-144-SR Japanese Study Group on Central Precocious Puberty. Journal of Clinical Endocrinology & Metabolism, 90(3), 1371-1376.
[13] De Sutter, P. (2007). Reproduction and fertility issues for transpeople. Principles of transgender medicine and surgery, 209- 222.
[14] Brill, S., & Pepper, R. (2013). The transgender child: A handbook for families and professionals. Cleis Press.
[15] Lev, A. I. (2004). Transgender emergence. Binghamton, NY: Haworth Press.
[16] Kuper, L. E., Nussbaum, R., & Mustanski, B. (2012). Exploring the diversity of gender and sexual orientation identities in an online sample of transgender individuals. Journal of sex research, 49(2-3), 244-254.
[17] Murad, M. H., Elamin, M. B., Garcia, M. Z., Mullan, R. J., Murad, A., Erwin, P. J., & Montori, V. M. (2010). Hormonal therapy and sex reassignment: a systematic review and meta‐analysis of quality of life and psychosocial outcomes. Clinical Endocrinology, 72(2), 214-231.
[18] Smith, Y. L., Van Goozen, S. H., Kuiper, A. J., & Cohen-Kettenis, P. T. (2005). Sex reassignment: Outcomes and predictors of treatment for adolescent and adult transsexuals. Psychological Medicine, 35(1), 89-99.
[19] Lawrence, A. A. (2003). Factors associated with satisfaction or regret following male-to-female sex reassignment
surgery. Archives of Sexual Behavior, 32(4), 299-315.
[20] De Cuypere, G., Elaut, E., Heylens, G., Van Maele, G., Selvaggi, G., T’Sjoen, G., ... & Monstrey, S. (2006). Long-term follow- up: Psychosocial outcome of Belgian transsexuals after sex reassignment surgery. Sexologies, 15(2), 126-133.
[21] Delemarre-van de Waal, H. A., & Cohen-Kettenis, P. T. (2006). Clinical management of gender identity disorder in adolescents: A protocol on psychological and paediatric endocrinology aspects. European Journal of Endocrinology, 155(suppl 1), S131-S137.
[22] [23]
58-82.
Smith, Y. L., van Goozen, S. H., & Cohen-Kettenis, P. T. (2001). Adolescents with gender identity disorder who were accepted
or rejected for sex reassignment surgery: A prospective follow-up study. Journal of the American Academy of Child & Adolescent
Psychiatry, 40(4), 472-481.
Steensma, T. D., Biemond, R., de Boer, F., & Cohen-Kettenis, P. T. (2011). Desisting and persisting gender dysphoria after
childhood: A qualitative follow-up study. Clinical Child Psychology and Psychiatry, 16(4), 499-516.
[24] de Vries, A. L., Steensma, T. D., Doreleijers, T. A., & Cohen‐Kettenis, P. T. (2011). Puberty suppression in adolescents with
gender identity disorder: A prospective follow‐up study. The Journal of Sexual Medicine, 8(8), 2276-2283.
[25] de Vries, A. L., McGuire, JK, Steensma, T. D., Wagenaar, E. C., Doreleijers, T. A., & Cohen‐Kettenis, P. T. (2014). Young
adult psychological outcome after puberty suppression and gender reassignment. Pediatrics, 134(4), 1-9.
[26] Zucker, K. J., Bradley, S. J., Owen-Anderson, A., Singh, D., Blanchard, R., & Bain, J. (2010). Puberty-blocking hormonal
therapy for adolescents with gender identity disorder: A descriptive clinical study. Journal of Gay & Lesbian Mental Health, 15(1),
[27] Cohen-Kettenis, P. T., & van Goozen, S. H. (1997). Sex reassignment of adolescent transsexuals: A follow-up study. Journal of
the American Academy of Child & Adolescent Psychiatry, 36(2), 263-271.
[28] Grant, J. M., Mottet, L. A., Tanis, J., Herman, J. L., Harrison, J., & Keisling, M. (2010). National Transgender Discrimination
Survey Report on health and health care. National Center for Transgender Equality and National Gay and Lesbian Task Force.
Washington, DC, 1-23.
Även:
https://www.jsm.jsexmed.org/article/S1743-6095(15)34443-X/fulltext
Och:
https://www.jsm.jsexmed.org/article/S1743-6095(15)33617-1/pdf